Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles | Zendy

M. Toftager | Zendy; Jeanette Bogstad | Zendy; Thue Bryndorf | Zendy; Kristine Løssl | Zendy; Janne Roskær | Zendy; T. Holland | Zendy; Lisbeth Prætorius | Zendy; Anne Zedeler | Zendy; Lisbeth Nilas | Zendy; Anja Pinborg | Zendy

Open Access

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

Author(s) -

M. Toftager,

Jeanette Bogstad,

Thue Bryndorf,

Kristine Løssl,

Janne Roskær,

T. Holland,

Lisbeth Prætorius,

Anne Zedeler,

Lisbeth Nilas,

Anja Pinborg

Publication year - 2016

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dew051

Subject(s) - ovarian hyperstimulation syndrome , medicine , agonist , randomized controlled trial , gonadotropin releasing hormone , gynecology , in vitro fertilisation , pregnancy , biology , luteinizing hormone , hormone , receptor , genetics

Is the risk of severe ovarian hyperstimulation syndrome (OHSS) similar in a short GnRH antagonist and long GnRH agonist protocol in first cycle IVF/ICSI patients less than 40 years of age?.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research